^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

ISG20 (Interferon Stimulated Exonuclease Gene 20)

i
Other names: ISG20, Interferon Stimulated Exonuclease Gene 20, HEM45, CD25, Promyelocytic Leukemia Nuclear Body-Associated Protein ISG20, Interferon Stimulated Exonuclease Gene 20kDa, Interferon-Stimulated Gene 20 KDa Protein, Estrogen-Regulated Transcript 45 Protein
Associations
10d
WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" Muteins. (PubMed, Cancer Immunol Res)
Pharmacokinetic-receptor occupancy (PK/RO) modeling showed that by masking wild-type IL2 in the periphery, WTX-124 produces high RO on TILs but low RO on peripheral lymphocytes, unlike non-alpha IL2s. These findings therefore identify the conditional activation of wild-type IL2 as a promising engineering strategy to improve IL2 tolerability without compromising its antitumor activity.
Journal
|
CD8 (cluster of differentiation 8) • IL2RA (Interleukin 2 receptor, alpha) • FOXP3 (Forkhead Box P3) • ISG20 (Interferon Stimulated Exonuclease Gene 20)
|
WTX-124
10d
Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis. (PubMed, Int J Mol Sci)
EVs enriched in platelet (CD49e) and endothelial (CD31) markers were associated with corticosteroid response, whereas EVs enriched with endothelial (CD105 and CD146) and B lymphocyte (CD19) markers were associated with mortality. Overall, EVs enriched in endothelial and monocyte markers may represent a candidate non-invasive tool for predicting corticosteroid response and mortality in AH, aiding risk stratification and early identification of non-responders for timely transplant evaluation.
Journal • IO biomarker
|
CD20 (Membrane Spanning 4-Domains A1) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL2RA (Interleukin 2 receptor, alpha) • ICAM1 (Intercellular adhesion molecule 1) • CD14 (CD14 Molecule) • MCAM (Melanoma Cell Adhesion Molecule) • CD31 (Platelet and endothelial cell adhesion molecule 1) • CD40 (CD40 Molecule) • ENG (Endoglin) • PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1) • VCAM1 (Vascular Cell Adhesion Molecule 1) • ISG20 (Interferon Stimulated Exonuclease Gene 20) • ITGA5 (Integrin Subunit Alpha 5) • SELP (Selectin P)
14d
Cutaneous epitheliotropic lymphoma with marked nuclear pleomorphism in a dog. (PubMed, J Vet Sci)
Here, we report atypical clinicopathological features observed in the case of CEL. These findings have potential biological, diagnostic, and prognostic relevance, emphasizing the need for further studies to elucidate their clinical significance and to expand the understanding of this disease.
Journal
|
CD8 (cluster of differentiation 8) • IL2RA (Interleukin 2 receptor, alpha) • PTPRC (Protein Tyrosine Phosphatase Receptor Type C) • CD5 (CD5 Molecule) • ISG20 (Interferon Stimulated Exonuclease Gene 20)
|
lomustine
17d
Gamma delta T cell reconstitution in Acute Lymphoblastic Leukemia patients post allogenic HSCT predicts clinical outcome and overall survival. (PubMed, Transpl Immunol)
Furthermore, donors with higher baseline percentages of γδ T cells, CD19+ B cells, CD4 T cells, Vδ2 Naïve, Vδ2 TemRA, CD3+CD25+, and Vδ2+CD25+; and low Effector Memory CD3+ and Vδ1+ T cells were associated with fewer Cytomegalovirus (CMV) reactivation in their recipients. The present study underscores the importance of compositional analysis of immune cells in both recipients and donors as a discerning predictive tool for anticipating long-term clinical outcomes following allogeneic HSCT and highlights the need for future validation in larger cohorts.
Clinical data • Journal
|
IL2RA (Interleukin 2 receptor, alpha) • CD4 (CD4 Molecule) • CD69 (CD69 Molecule) • ISG20 (Interferon Stimulated Exonuclease Gene 20)
17d
Bifidobacterium Breve SHMB 8001 Alleviates DSS-Induced Colitis in Mice Via Modulating the Intestinal Barrier and Gut Microbiota. (PubMed, J Food Sci)
B. breve SHMB 8001 represents a potential probiotic strain for alleviating colitis via normalizing intestinal homeostasis.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL2RA (Interleukin 2 receptor, alpha) • CD4 (CD4 Molecule) • CLDN1 (Claudin 1) • FOXP3 (Forkhead Box P3) • IL1B (Interleukin 1, beta) • MUC2 (Mucin 2) • ISG20 (Interferon Stimulated Exonuclease Gene 20) • OCLN (Occludin)
20d
Role of CD25 on resting Treg immune cell in mediating the effect of stearate biosynthesis microbiome pathway on lung adenocarcinoma. (PubMed, Medicine (Baltimore))
In addition, CD25 on resting regulatory T cell (Treg) was negatively correlated with LUAD. Of note, the mediation MR illustrated that in the presence of CD25 on resting Treg, PWY-5989 can promote the risk of LUAD by inhibiting the expression of CD25 on resting Treg. The study suggested a causal relationship between PWY-5989 and LUAD, which may be mediated by CD25 on resting Treg.
Journal
|
IL2RA (Interleukin 2 receptor, alpha) • ISG20 (Interferon Stimulated Exonuclease Gene 20)
|
IL2RA expression
21d
New P2 trial
|
ISG20 (Interferon Stimulated Exonuclease Gene 20)
26d
Temporal dynamics of mesenchymal stem cell administration influence immune modulation in a 4T1 breast cancer model. (PubMed, Cell Transplant)
Collectively, these findings demonstrate that the immunomodulatory effects of MSCs on breast cancer are highly dependent on the timing of their administration. Mesenchymal stem cells delivered during early tumor development enhance phenotypes consistent with antitumor potential and suppress tumor progression, whereas administration during later stages promotes immune evasion and tumor growth.
Preclinical • Journal
|
CD8 (cluster of differentiation 8) • IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL2RA (Interleukin 2 receptor, alpha) • CD4 (CD4 Molecule) • FASLG (Fas ligand) • IL10 (Interleukin 10) • GZMB (Granzyme B) • TGFB1 (Transforming Growth Factor Beta 1) • FOXP3 (Forkhead Box P3) • IL17A (Interleukin 17A) • ITGAX (Integrin Subunit Alpha X) • CD80 (CD80 Molecule) • CD86 (CD86 Molecule) • ISG20 (Interferon Stimulated Exonuclease Gene 20)
26d
Impact of Leukapheresis and Biological Risk Markers on Early Mortality in Patients with Hyperleukocytic Acute Myeloid Leukemia. (PubMed, Medicina (Kaunas))
In multivariate analysis, higher PB blast percentage, CD25 positivity, and ECOG PS ≥ 2 independently predicted poorer OS. Although LA did not reduce early mortality in the entire cohort, the loss of prognostic significance of elevated LDH, high PB blast percentage, PB monocyte burden, and CD25 expression in the LA group may suggest that the intervention can attenuate the impact of biologically aggressive disease.
Journal
|
IL2RA (Interleukin 2 receptor, alpha) • ISG20 (Interferon Stimulated Exonuclease Gene 20)
|
LDH elevation • IL2RA expression
26d
Aberrant CD25 and Increased CD123 Expression Are Common in Acute Myeloid Leukemia with KMT2A Partial Tandem Duplication and Are Associated with FLT3 Internal Tandem Duplication. (PubMed, Cancers (Basel))
AML with KMT2A-PTD shows distinctive immunophenotypic features with increased CD123 and aberrant CD25 expression, both associated with FLT3-ITD. These markers may have diagnostic and therapeutic relevance in this AML subtype.
Journal • IO biomarker
|
FLT3 (Fms-related tyrosine kinase 3) • KIT (KIT proto-oncogene, receptor tyrosine kinase) • DNMT3A (DNA methyltransferase 1) • RUNX1 (RUNX Family Transcription Factor 1) • KMT2A (Lysine Methyltransferase 2A) • CD38 (CD38 Molecule) • CD123 (Interleukin 3 Receptor Subunit Alpha) • IL2RA (Interleukin 2 receptor, alpha) • CD34 (CD34 molecule) • IL3RA (Interleukin 3 Receptor Subunit Alpha) • ISG20 (Interferon Stimulated Exonuclease Gene 20)
|
FLT3-ITD mutation • IL2RA expression
1m
Deficiency of SMARCB1 drives an immunosuppressive microenvironment in meningioma. (PubMed, Acta Neuropathol Commun)
The findings reveal that the infiltration of CD163+ macrophages in meningioma may be mediated by the IL-17/CSF1 axis through SMARCB1 regulation.
Journal
|
SMARCB1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily B, Member 1) • IL2RA (Interleukin 2 receptor, alpha) • CD163 (CD163 Molecule) • CD33 (CD33 Molecule) • CSF1 (Colony stimulating factor 1) • FOXP3 (Forkhead Box P3) • IL17A (Interleukin 17A) • BCL11B (BAF Chromatin Remodeling Complex Subunit BCL11B) • IL5 (Interleukin 5) • ISG20 (Interferon Stimulated Exonuclease Gene 20)
1m
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia. (PubMed, Leukemia)
Patients remaining on dasatinib maintained elevated NK cells with a more mature phenotype, suggesting a durable effect. These results highlight the greater dasa+blina immune activation, supporting a potential synergistic effect of the drug combination.
Journal • PD(L)-1 Biomarker • IO biomarker
|
PD-1 (Programmed cell death 1) • HAVCR2 (Hepatitis A Virus Cellular Receptor 2) • IL2RA (Interleukin 2 receptor, alpha) • CD69 (CD69 Molecule) • ISG20 (Interferon Stimulated Exonuclease Gene 20)
|
dasatinib • Iclusig (ponatinib) • Blincyto (blinatumomab)